IRCT20250308064974N1 IRCT 2025-09-29 Ghoum University of Medical Sciences Comparison of the effect of botulinum toxin a in patients with migraine headaches and treatment-resistant tension in people aged 20 to 70 in patients Comparison of the effect of botulinum toxin a in patients with migraine headaches and treatment-resistant tension in people aged 20 to 70 years 2025-10-23 anticipated 50 Complete https://irct.ir/trial/82286 interventional Randomization: N/A, Blinding: Not blinded, Placebo: Not used, Assignment: Single, Purpose: Treatment. 3 Migrain and tension headache. Intervention 1: First Intervention groupPatients with treatment-resistant chronic migraine headaches are in the first intervention group, receiving botulinum toxin type A subcutaneously with a fine insulin needle according to the preempt protocol. Intervention 2: Intervention group: Patients with treatment-resistant chronic tension headaches are in the second intervention group, who receive botulinum toxin type A subcutaneously with a fine insulin needle in the frontal, temporal, and occipital regions. No - There is not a plan to make this available Justification or reason for not sharing IPD is Due to the existence of personal information of patients and in order to protect privacy and observe medical ethics in maintaining patient confidentiality